13 results
·
19ms
·
Sources: EU EUDAMED, US FDA
VAX-D GENESIS SYSTEM (THERAPEUTIC TABLE)
FDA 510(k)
FDA Class 2
·Physical Medicine
JOBST forMen
FDA UDI
BSN MEDICAL, INC.·04042809843828·FOR MEN 30-40 MM HG KNEE HIGH CLOSED TOE EXTRA ...
Arx
FDA UDI
Life Spine, Inc.·00190837124472·
Arx
FDA UDI
Life Spine, Inc.·00190837130633·
MODIFICATION TO: STERILE COLLES CLASSIC FIXATOR
FDA 510(k)
FDA Class 2
·Orthopedic
N LATEX CYSTATIN C
FDA 510(k)
FDA Class 2
·Clinical Chemistry
HOMECHOICE AUTOMATED PD SET WITH CASSETTE
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - MOUNTAIN HOME·Product code FKX·April 11, 2013
1ST RESPONSE RESUSCITATOR, INFANT
FDA Adverse Event
Malfunction
·SMITHS MEDICAL ASD, INC. BY: GALEMED CORPORATION·Product code BTM·May 28, 2008
CAPSUREFIX NOVUS
FDA Adverse Event
Injury
·MEDTRONIC PUERTO RICO, INC.·Product code DTB·April 13, 2011
CABLE TENSIONER
FDA Adverse Event
Malfunction
·SYNTHES MONUMENT·Product code LXH·April 8, 2016
Conformer - Medium (Sterile)
FDA Recall
Terminated
·Gulden Ophthalmics·Product code HQX·November 29, 2002
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014